139 related articles for article (PubMed ID: 36722951)
21. Clinical utility of somatostatin receptor positron emission tomography imaging biomarkers for characterization of meningioma among incidental central nervous system lesions.
Ensign SF; Agarwal M; Klanderman M; Badawy M; Halfdanarson TR; Johnson DR; Sonbol MB; Kendi AT
Nucl Med Commun; 2023 Jul; 44(7):663-670. PubMed ID: 37158225
[TBL] [Abstract][Full Text] [Related]
22. Recurrence pattern analysis after [
Zollner B; Ganswindt U; Maihöfer C; Corradini S; Albert NL; Schichor C; Belka C; Niyazi M
Radiat Oncol; 2018 Jun; 13(1):110. PubMed ID: 29898747
[TBL] [Abstract][Full Text] [Related]
23. Complementary Molecular and Metabolic Characterization of Meningiomas With DOTATATE and FDG-PET: Advancing Treatment Planning and Prognostication.
Dressen MS; Muthukrishnan A; Tragon TR; Lieberman FS; Mountz JM
Clin Nucl Med; 2019 Jan; 44(1):e26-e27. PubMed ID: 30371576
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.
Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH
Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463
[TBL] [Abstract][Full Text] [Related]
25. Influence of
Stade F; Dittmar JO; Jäkel O; Kratochwil C; Haberkorn U; Debus J; Combs SE
Radiat Oncol; 2018 Apr; 13(1):58. PubMed ID: 29606149
[TBL] [Abstract][Full Text] [Related]
26. 68 Ga-FAPI04 Versus 68 Ga-DOTATATE PET/CT in a Patient With Multiple Meningioma.
Denizmen D; Isik EG; Buyukkaya F; Kuyumcu S
Clin Nucl Med; 2023 May; 48(5):e244-e245. PubMed ID: 36881633
[TBL] [Abstract][Full Text] [Related]
27. Potential impact of (68)Ga-DOTATOC PET/CT on stereotactic radiotherapy planning of meningiomas.
Nyuyki F; Plotkin M; Graf R; Michel R; Steffen I; Denecke T; Geworski L; Fahdt D; Brenner W; Wurm R
Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):310-8. PubMed ID: 19763565
[TBL] [Abstract][Full Text] [Related]
28. Detection of cranial meningiomas: comparison of ⁶⁸Ga-DOTATOC PET/CT and contrast-enhanced MRI.
Afshar-Oromieh A; Giesel FL; Linhart HG; Haberkorn U; Haufe S; Combs SE; Podlesek D; Eisenhut M; Kratochwil C
Eur J Nucl Med Mol Imaging; 2012 Sep; 39(9):1409-15. PubMed ID: 22669255
[TBL] [Abstract][Full Text] [Related]
29. 68 Ga-DOTATOC Pictorial Essay of Various Recurrent Meningiomas Rejected for Treatment With 177 Lu-DOTATATE : Is There a Place for Another Theranostic Examination?
Moreau A; Maureille A; Kryza D
Clin Nucl Med; 2024 Jul; 49(7):655-658. PubMed ID: 38689436
[TBL] [Abstract][Full Text] [Related]
30. 68 Ga-DOTATATE and 18 F-FDG PET Imaging of a Rare Chordoid Meningioma With Intracranial Recurrence and Extracranial Metastases.
Smith MV; Lang HJ; Donev K; Bendok BR; Yang M
Clin Nucl Med; 2024 Jul; 49(7):e354-e356. PubMed ID: 38598744
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of hitherto unknown brain meningioma detected on
Parghane RV; Talole S; Basu S
World J Nucl Med; 2019; 18(2):160-170. PubMed ID: 31040748
[TBL] [Abstract][Full Text] [Related]
32. [
Mahase SS; Roth O'Brien DA; No D; Roytman M; Skafida ME; Lin E; Karakatsanis NA; Osborne JR; Brandmaier A; Pannullo SC; Ramakrishna R; Stieg PE; Knisely JPS; Ivanidze J
Neurooncol Adv; 2021; 3(1):vdab012. PubMed ID: 33738446
[TBL] [Abstract][Full Text] [Related]
33.
Prasad RN; Perlow HK; Bovi J; Braunstein SE; Ivanidze J; Kalapurakal JA; Kleefisch C; Knisely JPS; Mehta MP; Prevedello DM; Raleigh DR; Mishra MV; Roberge D; Rogers CL; Palmer JD
Int J Radiat Oncol Biol Phys; 2022 Jul; 113(4):868-871. PubMed ID: 35772444
[No Abstract] [Full Text] [Related]
34. Magnetic resonance imaging, computed tomography, and 68Ga-DOTATOC positron emission tomography for imaging skull base meningiomas with infracranial extension treated with stereotactic radiotherapy--a case series.
Graf R; Plotkin M; Steffen IG; Wurm R; Wust P; Brenner W; Budach V; Badakhshi H
Head Face Med; 2012 Jan; 8():1. PubMed ID: 22217329
[TBL] [Abstract][Full Text] [Related]
35. (68)Ga-DOTANOC PET/CT detection of multiple extracranial localizations in a patient with anaplastic meningioma.
Golemi A; Ambrosini A; Cecchi P; Ruiu A; Chondrogiannis S; Farsad M; Rubello D
Rev Esp Med Nucl Imagen Mol; 2015; 34(4):258-60. PubMed ID: 25890891
[TBL] [Abstract][Full Text] [Related]
36. The Use of 68Ga-DOTA-(Tyr3)-Octreotate PET/CT for Improved Target Definition in Radiotherapy Treatment Planning of Meningiomas - A Case Report.
Grzbiela H; Tarnawski R; D'Amico A; Stąpór-Fudzińska M
Curr Radiopharm; 2015; 8(1):45-8. PubMed ID: 25808961
[TBL] [Abstract][Full Text] [Related]
37. 68Ga-DOTA-peptide PET/CT for radiotherapy planning and evaluating treatment response in the management of meningiomas.
Usmani S; Jain A; Hashmi SF; Mula-Hussain L; Riyami KA; Abubakar S; Shamim MS
J Pak Med Assoc; 2023 Jun; 73(6):1340-1343. PubMed ID: 37427649
[TBL] [Abstract][Full Text] [Related]
38. Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE/-TOC uptake.
Seystahl K; Stoecklein V; Schüller U; Rushing E; Nicolas G; Schäfer N; Ilhan H; Pangalu A; Weller M; Tonn JC; Sommerauer M; Albert NL
Neuro Oncol; 2016 Nov; 18(11):1538-1547. PubMed ID: 27106404
[TBL] [Abstract][Full Text] [Related]
39. DOTATATE PET/MR Imaging Differentiates Secondary-Progressive from de Novo World Health Organization Grade 3 Meningiomas.
Kim JT; Chang SJC; Haghdel A; Ramakrishna RR; Pannullo SC; Schwartz TH; Osborne JR; Magge RS; Fine HA; Cisse B; Stieg P; Lin E; Roytman M; Palmer JD; Karakatsanis NA; Pisapia D; Liechty B; Knisely JPS; Ivanidze J
AJNR Am J Neuroradiol; 2024 Jun; 45(6):773-780. PubMed ID: 38604734
[TBL] [Abstract][Full Text] [Related]
40. The significance of incidental brain uptake on 68Ga-DOTATATE PET-CT in neuroendocrine tumour patients.
Cleary JO; Yeung J; McMeekin H; Wilhelm T; Wagner T
Nucl Med Commun; 2016 Nov; 37(11):1197-205. PubMed ID: 27399848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
